Journal Information

Hepatitis Monthly is an international, peer-reviewed clinical journal committed to advancing the field of hepatology through the dissemination of high-quality, evidence-based, and interdisciplinary research. The journal primarily addresses clinicians and researchers, including gastroenterologists, hepatologists, infectious disease specialists, internists, and other healthcare professionals engaged in the management and study of liver diseases.

Established in 2002 by Professor Seyed-Moayed Alavian, Hepatitis Monthly serves as an authoritative platform for the publication of clinically relevant and scientifically robust studies that contribute to the understanding of liver diseases, particularly hepatitis, across diverse populations and healthcare settings.

The journal aims to promote the integration of clinical practice and research by publishing articles that enhance knowledge of disease mechanisms, improve diagnostic and therapeutic approaches, and inform health policy and clinical decision-making in hepatology.

Journal Scope:

• Viral hepatitis and related infections
• Chronic liver diseases and cirrhosis
• Liver fibrosis, liver failure, and associated complications
• Non-alcoholic and metabolic-associated fatty liver disease
• Hepatocellular carcinoma and other hepatic malignancies
• Liver transplantation and post-transplant outcomes
• Advances in diagnostic modalities and therapeutic interventions
• Molecular and cellular mechanisms of liver diseases
• Epidemiology, prevention, and public health aspects of liver diseases
• Emerging therapies and clinical innovations of liver diseases

By publishing original investigations, critical syntheses, and evidence-based perspectives, Hepatitis Monthly seeks to facilitate scientific exchange, support clinical excellence, and advance global hepatology.